Free Equity Delivery
Flat ₹10 per Trade in Intraday & F&O
Sunrest Lifescience IPO is a fixed price issue of ₹10.85 crores. The issue is entirely a fresh issue of 0.13 crore shares of ₹10.85 crore.
Sunrest Lifescience IPO bidding started from Nov 7, 2023 and ended on Nov 9, 2023. The allotment for Sunrest Lifescience IPO was finalized on Nov 15, 2023. The shares got listed on NSE SME on Nov 20, 2023.
Sunrest Lifescience IPO price is ₹84.00 per share . The lot size for an application is 1,600. The minimum amount of investment required by an individual investor (retail) is ₹1,34,400 (1600 shares). The minimum lot size investment for HNI is 2 lots (3,200 shares), amounting to ₹2,68,800.
Mark Corporate Advisors Pvt.Ltd. is the book running lead manager and Skyline Financial Services Pvt.Ltd. is the registrar of the issue. The market maker of the company is Svcm Securities Pvt.Ltd..
Refer to Sunrest Lifescience IPO RHP for detailed Information.
| IPO Date | November 7, 2023 to November 9, 2023 |
| Listing Date | November 20, 2023 |
| Face Value | ₹10 per share |
| Issue Price Band | |
| Issue Price Final | ₹84 per share |
| Lot Size | 1,600 Shares |
| Sale Type | Fresh Capital |
| Total Issue Size | 12,91,200 shares (aggregating up to ₹10.85 Cr) |
| Reserved for Market Maker | 65,600 shares Svcm Securities Pvt.Ltd. (aggregating up to ₹0.5510 Cr) |
| Net Offered to Public | 12,25,600 shares (aggregating up to ₹10.30 Cr) |
| Issue Type | Fixed Price IPO |
| Listing At | NSE SME |
| Share Holding Pre Issue | 30,00,000 shares |
| Share Holding Post Issue | 42,91,200 shares |
Sunrest Lifescience IPO offers total 12,91,200 shares. Out of which 6,12,800 (47.46%) allocated to NII, 6,12,800 (47.46%) allocated to RII.
| Investor Category | Shares Offered |
|---|---|
| Market Maker Shares Offered | 65,600 (5.08%) |
| NII (HNI) Shares Offered | 6,12,800 (47.46%) |
| Retail Shares Offered | 6,12,800 (47.46%) |
| Total Shares Offered | 12,91,200 (100.00%) |
Sunrest Lifescience IPO opens on November 7, 2023, and closes on November 9, 2023.
| IPO Open Date | Tue, Nov 7, 2023 |
| IPO Close Date | Thu, Nov 9, 2023 |
| Tentative Allotment | Wed, Nov 15, 2023 |
| Initiation of Refunds | Thu, Nov 16, 2023 |
| Credit of Shares to Demat | Fri, Nov 17, 2023 |
| Tentative Listing Date | Mon, Nov 20, 2023 |
| Cut-off time for UPI mandate confirmation | 5 PM on Thu, Nov 9, 2023 |
Investors can bid for a minimum of 1,600 shares and in multiples thereof. The following table depicts the minimum and maximum investment by Individual Investors (Retail) and HNI in terms of shares and amount.
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retail (Min) | 1 | 1,600 | ₹1,34,400 |
| Retail (Max) | 1 | 1,600 | ₹1,34,400 |
| HNI (Min) | 2 | 3,200 | ₹2,68,800 |
Note : The value will be calculated using Equity Dilution = Share Holding Pre Issue - Share Holding Post Issue
Incorporated in 2017, Sunrest Lifescience Limited offers a diverse range of healthcare and personal care products.
The company's product range includes Capsules, Tablets, Syrup, Ointment, Gel, mouthwash, Solution, Suspension, Dry Powders, and Toothpaste. Sunrest Lifescience's product portfolio encompasses an extensive range of drugs such as Anti-Bacterial, Anti Diarrheal, AntiFungal, Anti Malerial, Anti Diabetic, Dental Cure, Anti Protozol, Anti Histamine, Anti-Hypertensive drugs, Cosmetic, Anti Parasitic, Multivitamin, Multimineral, Nutraceutical, and Anti-inflammatory.
The company gets its products manufactured by third-party pharma product manufacturers which also includes Trilend Pharmaceuticals Private Limited (Trilend), a Sunrest group company. The company has 43 third-party manufacturers across these states: Gujarat, Punjab, Maharashtra, Haryana, Himachal Pradesh, Uttarakhand and Madhya Pradesh.
Sunrest Lifescience's clientele includes stockists and Super Stockists & in turn, it is available at Chemist shops, Dispensaries, Hospitals, etc.
With 18 Registered Trademarks for 32 products, Sunrest Lifescience is committed to delivering high-quality products to its customers.
Sunrest Lifescience Limited's revenue decreased by -8.32% and profit after tax (PAT) rose by 162.91% between the financial year ending with March 31, 2023 and March 31, 2022.
| Period Ended | 30 Jun 2023 | 31 Mar 2023 | 31 Mar 2022 | 31 Mar 2021 |
| Assets | 1,706.28 | 1,671.37 | 1,301.97 | 948.15 |
| Total Income | 563.58 | 2,467.05 | 2,690.99 | 1,694.91 |
| Profit After Tax | 75.08 | 204.31 | 77.71 | 16.55 |
| Net Worth | 386.60 | 311.52 | 107.20 | 29.49 |
| Reserves and Surplus | 86.60 | 11.52 | 106.20 | 28.49 |
| Total Borrowing | 347.32 | 214.32 | 323.83 | 231.55 |
| Amount in ₹ Lakhs | ||||
The market capitalization of Sunrest Lifescience IPO is ₹36.05 Cr.
| KPI | Values |
|---|---|
| ROE | 53% |
| ROCE | 98% |
| Debt/Equity | 0.64 |
| RoNW | 65.59% |
The Issue Proceeds from the Fresh Issue will be utilized towards the following objects:
1. Meeting Working Capital Requirements
2. General Corporate Purpose
3. Meeting Public Issue Expenses
[Dilip Davda] The company operates on third party contract model of pharma business. It marked inconsistency in its top lines for the reported periods and sudden surge in bottom lines for the last 15 months’ performance that raises concern over the sustainability. Based on annualized FY24 super earnings, the issue appears fully priced. The small equity post-IPO indicates longer duration for migration to mainboard. Well-informed/cash surplus investors may park funds for the long-term rewards. Read detail review...
| Listing Date | November 20, 2023 |
| BSE Script Code | |
| NSE Symbol | SUNREST |
| ISIN | INE0PLZ01012 |
| Final Issue Price | ₹84 per share |
| Price Details | NSE SME |
|---|---|
| Final Issue Price | ₹84.00 |
| Open | ₹84.00 |
| Low | ₹79.80 |
| High | ₹84.00 |
| Last Trade | ₹79.80 |
Sunrest Lifescience Ltd.
FF-41, Ajay Tenament-6,
Near Canal Near Ritanagar,
Bus Stand Vastral Road,
Ahmedabad, Gujarat, 382415
Phone: +91-079 - 29918245
Email: info@sunrestlifescience.com
Website: https://sunrestlifescience.com/
Skyline Financial Services Pvt.Ltd.
Phone: 02228511022
Email: Virenr@Skylinerta.Com
Website: https://www.skylinerta.com/ipo.php
Sunrest Lifescience IPO is a SME IPO of 12,91,200 equity shares of the face value of ₹10 aggregating up to ₹10.85 Crores. The issue is priced at ₹84 per share. The minimum order quantity is 1600.
The IPO opens on November 7, 2023, and closes on November 9, 2023.
Skyline Financial Services Pvt.Ltd. is the registrar for the IPO. The shares are proposed to be listed on NSE SME.
Zerodha customers can apply online in Sunrest Lifescience IPO using UPI as a payment gateway. Zerodha customers can apply in Sunrest Lifescience IPO by login into Zerodha Console (back office) and submitting an IPO application form.
Steps to apply in Sunrest Lifescience IPO through Zerodha
Visit Zerodha IPO Application Process Review for more detail.
The Sunrest Lifescience IPO opens on November 7, 2023 and closes on November 9, 2023.
Sunrest Lifescience IPO lot size is 1600, and the minimum amount required for application is ₹1,34,400.
You can apply in Sunrest Lifescience IPO online using either UPI or ASBA as a payment method. ASBA IPO application is available in the net banking of your bank account. UPI IPO Application is offered by brokers who don't offer banking services. Read more detail about applying IPO online through Zerodha, Upstox, 5Paisa, Nuvama, HDFC Bank, and SBI Bank.
The finalization of Basis of Allotment for Sunrest Lifescience IPO will be done on Wednesday, November 15, 2023, and the allotted shares will be credited to your demat account by Friday, November 17, 2023. Check the Sunrest Lifescience IPO allotment status.
The Sunrest Lifescience IPO listing date is on Monday, November 20, 2023.
Useful Articles
RHP